Convatec (CTEC) Stock Price, Fundamentals & Analysis

What CTEC does

Convatec (CTEC) is a Healthcare stock in the Medical Instruments & Supplies industry, listed on the London Stock Exchange. The company develops, manufactures, and sells medical products for managing chronic conditions, including advanced wound care, ostomy care, continence care, and infusion care solutions. It serves pharmacies, hospitals, and other healthcare providers across Europe, North America, and internationally. Within the broader Healthcare space, peers include Smith & Nephew (SN), GSK plc (GSK), AstraZeneca (AZN), and Haleon (HLN).

Key numbers explained

• 2.09 GBP is the current share price, the amount you would pay for one share at this moment.
• The -1.04% price change today shows the intraday move relative to the previous close.
• Market capitalisation of 4.03 mld. GBP is the total value of all outstanding shares, calculated as price × shares outstanding.
• The trailing P/E ratio of 41.9 divides the current share price by the last 12 months' earnings per share (0.05 USD), showing how much investors pay per pound of earnings.
• The forward P/E ratio of 12.1 uses expected future earnings, which can look very different from the trailing figure when earnings are volatile or one-time items are involved.
• A dividend yield of 2.65% tells you the annual dividend as a percentage of the current share price; the ex-dividend date is 20 aug. 2026.
• The share of earnings paid out as dividends is 117%, meaning the dividend exceeds trailing earnings, often funded from reserves or future expectations.
• Beta of 0.77 suggests the stock tends to move less than the overall market.
• The 52-week range of 1,93 – 2,59 shows the lowest and highest prices over the past year, with the current price near the lower end.
• Revenue of 2,49 mld. USD and 4.4% year-over-year growth describe the top-line scale and recent trend.
• Profit margin of 5% and operating margin of 14.4% show how much of each revenue pound turns into net profit and operating profit, respectively.
• Return on equity of 7.7% measures how effectively the company generates profit from shareholders' capital.
• The debt-to-equity ratio of 121.8% indicates that debt exceeds equity, which can amplify risk in rising-rate environments.
• Price-to-book of 378,41 compares the share price to the book value per share; a very high figure can signal that the market values intangibles or future earnings far above the accounting net asset value.

What to watch

Investors typically monitor several factors for a stock like CTEC. Earnings releases and guidance updates, with the next report expected on 4 aug. 2026, can move the share price. Currency movements matter because revenue is reported in USD while the share price is in GBP. Regulatory changes in the medical devices sector, pricing pressure from healthcare systems, and product-cycle milestones can all affect results. The company's capital structure, shown by the 121.8% debt-to-equity ratio, is worth tracking alongside any changes in dividend policy. Broader Healthcare sector trends and the performance of peers such as Smith & Nephew (SN) or GSK plc (GSK) provide useful context.